TY - JOUR
T1 - The incidence and risk factors for surgical site infection in older adults after gastric cancer surgery
T2 - A STROBE-compliant retrospective study
AU - Kim, Jung Ho
AU - Kim, Jinnam
AU - Lee, Woon Ji
AU - Seong, Hye
AU - Choi, Heun
AU - Ahn, Jin Young
AU - Jeong, Su Jin
AU - Ku, Nam Su
AU - Son, Taeil
AU - Kim, Hyoung Il
AU - Han, Sang Hoon
AU - Choi, Jun Yong
AU - Kim, Chang Oh
AU - Yeom, Joon Sup
AU - Hyung, Woo Jin
AU - Song, Young Goo
AU - Noh, Sung Hoon
AU - Kim, June Myung
AU - Levin, Anna S.
N1 - Funding Information:
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2017R1C1B5017875). This study was supported by a faculty research grant of Yonsei University College of Medicine (6-2017-0054).
Publisher Copyright:
© 2019 the Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Surgical site infection (SSI) is a well-known complication in older adults. However, there have been no studies on SSI after gastrectomy in older adults. Therefore, we aimed to investigate the incidence, risk factors, and outcomes of SSIs after gastrectomy in older adults.We performed a retrospective cohort study of older adults, aged 65 years or older, who underwent gastrectomy between January 2015 and December 2015 at the Severance Hospital in Seoul, Korea. The incidence and outcomes of SSIs after gastrectomy were evaluated, and the risk factors for SSI were identified using multivariate analyses.We identified 353 older adults who underwent gastrectomy. Of these, 25 patients (7.1%) developed an SSI. Multivariate analysis indicated that open surgery (odds ratio, 2.71; 95% confidence interval, 1.13-6.51; P=.03) and a longer operation time (odds ratio, 1.01; 95% confidence interval, 1.00-1.01; P=.04) were independent risk factors for SSI after gastrectomy. In the SSI group, the incidence of postoperative fever (84.0% vs 51.8%; P<.001), length of postoperative hospital stay (13 days vs 6 days; P<.001), and re-admission rates within 30 days postoperatively (32.0% vs 3.4%; P<.001) were significantly higher than those in the non-SSI group.The risk factors for SSI in older adults after gastrectomy were open surgery and a longer operation time. When an SSI occurred, the postoperative hospital stay was prolonged and the chances of having a postoperative fever and being re-admitted within 30 days increased.
AB - Surgical site infection (SSI) is a well-known complication in older adults. However, there have been no studies on SSI after gastrectomy in older adults. Therefore, we aimed to investigate the incidence, risk factors, and outcomes of SSIs after gastrectomy in older adults.We performed a retrospective cohort study of older adults, aged 65 years or older, who underwent gastrectomy between January 2015 and December 2015 at the Severance Hospital in Seoul, Korea. The incidence and outcomes of SSIs after gastrectomy were evaluated, and the risk factors for SSI were identified using multivariate analyses.We identified 353 older adults who underwent gastrectomy. Of these, 25 patients (7.1%) developed an SSI. Multivariate analysis indicated that open surgery (odds ratio, 2.71; 95% confidence interval, 1.13-6.51; P=.03) and a longer operation time (odds ratio, 1.01; 95% confidence interval, 1.00-1.01; P=.04) were independent risk factors for SSI after gastrectomy. In the SSI group, the incidence of postoperative fever (84.0% vs 51.8%; P<.001), length of postoperative hospital stay (13 days vs 6 days; P<.001), and re-admission rates within 30 days postoperatively (32.0% vs 3.4%; P<.001) were significantly higher than those in the non-SSI group.The risk factors for SSI in older adults after gastrectomy were open surgery and a longer operation time. When an SSI occurred, the postoperative hospital stay was prolonged and the chances of having a postoperative fever and being re-admitted within 30 days increased.
UR - http://www.scopus.com/inward/record.url?scp=85070559733&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070559733&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000016739
DO - 10.1097/MD.0000000000016739
M3 - Article
C2 - 31393386
AN - SCOPUS:85070559733
VL - 98
JO - Medicine (United States)
JF - Medicine (United States)
SN - 0025-7974
IS - 32
M1 - e16739
ER -
